https://doi.org/10.1002/aenm.202301758
L
Ling Ni
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
184
Papers
7.3K
Citations
41
h-index
98
i10-index
Ling Ni is an academic researcher from Kunming Institute of Botany. The author has contributed to research in topics: Immunotherapy and Immune Responses & Immune Cell Function and Interaction & Cancer Immunotherapy and Biomarkers. The author has an h-index of 41, co-authored 157 publications.
ORCID: 0000-0003-1569-882XPapers by this author
worksNonaqueous Liquid Electrolytes for Sodium‐Ion Batteries: Fundamentals, Progress and Perspectives
2023 · Advanced Energy Materials · 162 citations
STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection
2023 · The Journal of Experimental Medicine · 107 citations
https://doi.org/10.1084/jem.20220686
Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8+ and CD4+ T Cells
2016 · EBioMedicine · 63 citations
https://doi.org/10.1016/j.ebiom.2016.01.029
Five New Alkaloids from Cephalotaxus lanceolata and C. fortunei var. alpina
2016 · Natural Products and Bioprospecting · 39 citations
https://doi.org/10.1007/s13659-016-0093-7
Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39
2025 · The Journal of Experimental Medicine · 25 citations
https://doi.org/10.1084/jem.20240445
NR4A1 transcriptionally regulates the differentiation of stem-like CD8+ T cells in the tumor microenvironment
2024 · Cell Reports · 20 citations
https://doi.org/10.1016/j.celrep.2024.114301
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat